WERFEN secures contract for Blood-testing reagents PROVISION OF REAGENTS AND ANNEXED REFERENCES FOR HIGH-RESOLUTION HLA TYPING IN THE CONTEXT OF NEXT GENERATION SEQUENCING NGS ON THE MISEQ AND NANOPORE PLATFORMS

France, March 12 -- France based WERFEN has secured contract from Etablissement francais du sang for Blood-testing reagents PROVISION OF REAGENTS AND ANNEXED REFERENCES FOR HIGH-RESOLUTION HLA TYPING IN THE CONTEXT OF NEXT GENERATION SEQUENCING NGS ON THE MISEQ AND NANOPORE PLATFORMS. The value of the contract is not disclosed.

Published by HT Digital Content Services with permission from Pivotal Sources....